Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
COHANCE LIFESCIENCES LTD.
Cohance Lifesciences Ltd.
NSE: COHANCE | BSE: 543064
Expensive Performer
Download real time
989.85
-29.95
(
-2.94
%)
27.22% Fall from 52W High
305.5K
NSE+BSE Volume
High vol. this week
NSE
10 Sep, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Ltd. Corporate Filings & Announcements
Latest corporate announcements and filings from Cohance Lifesciences Ltd. on BSE
Get corporate announcements alerts
Hourly Digest
Daily Digest
All
News
Earnings Calls
Corporate Announcements
Research Reports
VOTE: Is Suven Pharmaceuticals Ltd. worth buying?
28 Votes:
Buy
67.86%
Sell
14.29%
Hold
17.86%
BUY
SELL
HOLD
RESEARCH REPORTS
Buy
SEE REPORTS >
29 May 2025
pdf
Cohance Lifesciences..
by ICICI Securities Limited
| Target:
1365
| Upside:
37.90%
Buy
SEE REPORTS >
29 May 2025
pdf
Cohance Lifesciences..
by BOB Capital Markets Ltd.
| Target:
1328
| Upside:
34.16%
All reports of COHANCE